Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis - Gillespie, Stephen H; Crook, Angela M; McHugh, Timothy D; Mendel, Carl M; Meredith, Sarah K; Murray, Stephen R; Pappas, Frances; Phillips, Patrick P.J; Nunn, Andrew J (The New England journal of medicine, 2014)
Keywords: Adult; Antibacterial agents; Antibiotics; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antitubercular Agents - adverse effects; Antitubercular Agents - therapeutic use; Bacterial diseases; Biological and medical sciences; Double-Blind Method; Double-blind studies; Drug Administration Schedule; Drug development; Drug therapy; Drug Therapy, Combination; Ethambutol; Ethambutol - therapeutic use; Female; Fluoroquinolones - adverse effects; Fluoroquinolones - therapeutic use; General aspects; HIV Seropositivity - complications; Human bacterial diseases; Humans; Infectious diseases; Isoniazid; Isoniazid - therapeutic use; Kaplan-Meier Estimate; Male; Medical sciences; Motivation; Moxifloxacin; Mycobacterium tuberculosis - isolation & purification; Patients; Pharmacology. Drug treatments; Pyrazinamide; Pyrazinamide - therapeutic use; Rifampin; Rifampin - therapeutic use; Sensitivity analysis; Tuberculosis; Tuberculosis and atypical mycobacterial infections; Tuberculosis, Pulmonary - complications; Tuberculosis, Pulmonary - drug therapy; Young Adult; United Kingdom--UK; South Africa; Infection; Medicine; Fluoroquinolone derivatives; Tuberculosis; Bacteriosis; Mycobacterial infection; Moxifloxacin; Antibacterial agent; Quinolone derivatives